- Home
- PEPG vs NRC Comparison
PEPG vs NRC Comparison
Compare PEPG & NRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PEPG
- NRC
- Stock Information
- Founded
- PEPG 2018
- NRC 1981
- Country
- PEPG United States
- NRC United States
- Employees
- PEPG N/A
- NRC N/A
- Industry
- PEPG Biotechnology: Pharmaceutical Preparations
- NRC Biotechnology: Commercial Physical & Biological Resarch
- Sector
- PEPG Health Care
- NRC Health Care
- Exchange
- PEPG Nasdaq
- NRC Nasdaq
- Market Cap
- PEPG 317.6M
- NRC 278.8M
- IPO Year
- PEPG 2022
- NRC N/A
- Fundamental
- Price
- PEPG $5.70
- NRC $16.08
- Analyst Decision
- PEPG Strong Buy
- NRC
- Analyst Count
- PEPG 6
- NRC 0
- Target Price
- PEPG $9.50
- NRC N/A
- AVG Volume (30 Days)
- PEPG 708.7K
- NRC 103.4K
- Earning Date
- PEPG 11-12-2025
- NRC 10-27-2025
- Dividend Yield
- PEPG N/A
- NRC 4.00%
- EPS Growth
- PEPG N/A
- NRC N/A
- EPS
- PEPG N/A
- NRC 0.71
- Revenue
- PEPG N/A
- NRC $139,102,000.00
- Revenue This Year
- PEPG N/A
- NRC N/A
- Revenue Next Year
- PEPG N/A
- NRC N/A
- P/E Ratio
- PEPG N/A
- NRC $22.56
- Revenue Growth
- PEPG N/A
- NRC N/A
- 52 Week Low
- PEPG $0.88
- NRC $9.76
- 52 Week High
- PEPG $6.85
- NRC $20.11
- Technical
- Relative Strength Index (RSI)
- PEPG 63.13
- NRC 74.96
- Support Level
- PEPG $4.71
- NRC $14.75
- Resistance Level
- PEPG $5.20
- NRC $14.18
- Average True Range (ATR)
- PEPG 0.46
- NRC 0.71
- MACD
- PEPG 0.07
- NRC 0.26
- Stochastic Oscillator
- PEPG 84.25
- NRC 98.01
About PEPG PepGen Inc.
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.
About NRC National Research Corporation (Delaware)
National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. It operates in the United States and Canada, of which key revenue is derived from the United States.